Key result
New minimally invasive, off-pump, and biologic surgical approaches fundamentally change CAD therapy.
Why the study?
Fundamental changes in surgical therapy for atherosclerotic coronary artery disease are occurring, including new techniques and strategies that require overview.
Answers are grounded in this paper and cite their sources.
This review highlights emerging surgical and biologic techniques for treating atherosclerotic coronary artery disease, including minimally invasive CABG and gene therapy.
Fundamental changes in the therapy of atherosclerotic coronary artery disease, in both technique and strategy, are occurring in the practice of cardiac surgery. New surgical approaches to coronary artery bypass grafting include the use of "mini" incisions and off-bypass techniques as well as the more widespread use of arterial conduits. Furthermore, the treatment of adult heart disease, in particular coronary artery disease, may be entering a period of fundamental change with the advent of nongrafting techniques, such as transmyocardial revascularization, therapeutic angiogenesis, and gene therapy. This article provides an overview of these new approaches, which involve either modifications of current coronary artery bypass grafting techniques or the novel use of biologic revascularization.
No takes yet. Share an insight, caveat, or question.
Todd K. Rosengart (1999) conducted a review in atherosclerotic coronary artery disease. New surgical and nongrafting approaches was evaluated. New surgical approaches, including minimally invasive techniques, off-pump bypass, and biologic revascularization, represent fundamental changes in the therapy of coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: